Which pregnancy category does Ketamine fall under?

Ketamine is classified as Category C in terms of its effects on pregnancy. This classification indicates that while animal studies may show adverse effects on the fetus, there is insufficient data from human studies. FDA Category C suggests that the potential benefits of administering the drug during pregnancy might outweigh the risks, but caution is warranted. It is essential to consider this classification in a clinical setting, especially when treating pregnant patients, to ensure that the risks and benefits are thoroughly evaluated and discussed.

The other categories provide a clearer picture of the risk levels associated with medication use during pregnancy. Category A indicates controlled studies have failed to demonstrate a risk to the fetus in the first trimester, while Category D denotes evidence of risk to the fetus but potential benefits could warrant use in certain situations. Category B suggests no risk in animal studies, but not enough data in humans. Thus, Ketamine's Category C designation reflects the uncertainty and caution that should be exercised when considering its use during pregnancy.